Yolanda Hernandez

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Diagnostic performance of the TR Chagas Bio-Manguinhos rapid test for detecting anti-Trypanosoma cruzi IgG in human samples from three Southern Cone countries.

Diagnostic performance of the TR Chagas Bio-Manguinhos rapid test for detecting anti-Trypanosoma cruzi IgG in human samples from three Southern Cone countries.

Journal: PLoS neglected tropical diseases

Published: January 05, 2026

Performance Assessment of ELISA Using the Trypanosoma cruzi-Specific Antigen Tc323 for the Diagnosis of Chronic Chagas Disease.

Performance Assessment of ELISA Using the Trypanosoma cruzi-Specific Antigen Tc323 for the Diagnosis of Chronic Chagas Disease.

Journal: ACS infectious diseases

Published: November 16, 2024

Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population.

Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population.

Journal: Memorias do Instituto Oswaldo Cruz

Published: August 08, 2024

Characterization of Novel Trypanosoma cruzi-Specific Antigen with Potential Use in the Diagnosis of Chagas Disease.

Characterization of Novel Trypanosoma cruzi-Specific Antigen with Potential Use in the Diagnosis of Chagas Disease.

Journal: International journal of molecular sciences

Published: November 07, 2023

IgE antibodies against Trypanosoma cruzi arginine kinase in patients with chronic Chagas disease.

IgE antibodies against Trypanosoma cruzi arginine kinase in patients with chronic Chagas disease.

Journal: Molecular immunology

Published: November 25, 2020

The cytosolic tryparedoxin peroxidase from Trypanosoma cruzi induces a pro-inflammatory Th1 immune response in a peroxidatic cysteine-dependent manner.

The cytosolic tryparedoxin peroxidase from Trypanosoma cruzi induces a pro-inflammatory Th1 immune response in a peroxidatic cysteine-dependent manner.

Journal: Immunology

Published: September 17, 2020

New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up.

New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up.

Journal: Antimicrobial agents and chemotherapy

Published: March 12, 2020

Ex vivo characterization of Breg cells in patients with chronic Chagas disease.

Ex vivo characterization of Breg cells in patients with chronic Chagas disease.

Journal: Scientific reports

Published: February 06, 2020

Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.

Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.

Journal: Trials

Published: August 21, 2019

In Silico Guided Discovery of Novel Class I and II Trypanosoma cruzi Epitopes Recognized by T Cells from Chagas' Disease Patients.

In Silico Guided Discovery of Novel Class I and II Trypanosoma cruzi Epitopes Recognized by T Cells from Chagas' Disease Patients.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: July 23, 2019

Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.

Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.

Journal: Trials

Published: January 08, 2019

Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood.

Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood.

Journal: Revista da Sociedade Brasileira de Medicina Tropical

Published: October 21, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026